Smith & Nephew SNATS Inc. (SNN)
NYSE: SNNHealth CareIndustrial SpecialtiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 26.89 +0.04%
SNN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $11.25B
- P/E (TTM)
- 18.29
- Forward P/E
- 11.16
- EPS (TTM)
- $1.47
- Dividend yield
- 1.48% ($0.397)
- Ex-dividend date
- Oct 2, 2026
- 52-week range
- 26.12 – 37.51
- Day range
- 26.84 – 27.13
- Volume / Avg
- 1.05M / 1.66M
- Beta
- —
- Shares outstanding
- 418.52M
52-week range
SNN stock today
Smith & Nephew SNATS (SNN) closed at $26.89 on Oct 7, up 0.07% (+$0.02), versus the S&P 500's 0.22% decline. Shares are 28.3% below their 52-week high of $37.51, set on Oct 22, 2025 and 2.9% above the 52-week low of $26.12, near the bottom of the past year's range. SNN is down 18.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 24.7%.
At 18.3x trailing earnings, Smith & Nephew SNATS trades below the peer-group median of 21.9x. Its forward P/E of 11.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Smith & Nephew SNATS pays an annual dividend of $0.397 per share, a 1.48% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Smith & Nephew SNATS
Company profileSmith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Dr. Deepak S. Nath Ph.D.
- Headquarters
- Watford
- Employees
- 17,000
- Website
- smith-nephew.com
Financial highlights
Full financialsIn fiscal 2025, Smith & Nephew SNATS generated $6.16 billion in revenue, up 6.1% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $625.0 million (+51.7% year over year), for a net margin of 10.1% versus a median of 7.1% in the prior 5 years. Gross margin was 68.0% (down from 69.6%) and operating margin 12.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $6.16B | $5.81B | $5.55B | $5.21B | $5.21B |
| Growth | +6.09% | +4.70% | +6.40% | +0.06% | +14.30% |
| Net income | $625.00M | $412.00M | $263.00M | $223.00M | $524.00M |
| EPS (diluted) | $0.716 | $0.47 | $0.301 | $0.255 | $0.597 |
Analyst forecast
ForecastConsensus (6 analysts)
hold
Avg. price target
$32.32+20.19%
- Strong buy 1
- Buy 0
- Hold 5
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Dividends
Dividend history- Annual dividend
- $0.397
- Dividend yield
- 1.48%
- Last payment
- $0.312
- Ex-dividend date
- Oct 2, 2026
Smith & Nephew SNATS peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AITApplied Industrial Technologies Inc. | 334.58 | -3.02% | $12.29B | vs SNN |
| ALGNAlign Technology Inc. | 139.87 | -1.12% | $9.94B | vs SNN |
| MASMasco Corporation | 68.87 | -1.52% | $13.58B | vs SNN |
| MSAMSA Safety Incorporated | 179.28 | -1.74% | $6.92B | vs SNN |
| MTRNMaterion Corporation | 290.72 | -6.87% | $6.06B | vs SNN |
| ZBHZimmer Biomet Holdings Inc. | 88.49 | -1.33% | $16.88B | vs SNN |
| POOLPool Corporation | 154.14 | -2.59% | $5.60B | vs SNN |
| AZZAZZ Inc. | 138.51 | -2.18% | $4.16B | vs SNN |
Indexes, lists and sector
Appears in lists
Smith & Nephew SNATS stock FAQ
What is Smith & Nephew SNATS's stock price today?
SNN last traded at $26.89 as of Oct 7, 4:00 PM EDT, up 0.07% on the day. Prices are delayed at least 15 minutes.
Does Smith & Nephew SNATS pay a dividend?
Yes. Smith & Nephew SNATS pays $0.397 per share annually, a 1.48% yield. The most recent dividend of $0.312 had an ex-dividend date of Oct 2, 2026.
What is SNN's P/E ratio?
SNN trades at a trailing P/E ratio of 18.29 and a forward P/E of 11.16, compared with a median of 21.9 for its closest peers.
Who is Smith & Nephew SNATS's CEO?
Dr. Deepak S. Nath Ph.D. is the chief executive officer of Smith & Nephew SNATS Inc., which has about 17,000 employees.
Has SNN ever split its stock?
Yes. The most recent SNN stock split was a 2499-for-1000 split on Oct 15, 2014, one of 2 splits on record.
What is the SNN 52-week high?
The 52-week high for SNN is $37.51 and the 52-week low is $26.12. The stock is currently 28.3% below its high.